Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Wedbush PacGrow Life Sciences Hosts Management Access Conference, Offers Investors Industry Insight
  • USA - English


News provided by

Wedbush Securities

Aug 13, 2013, 11:00 ET

Share this article

Share toX

Share this article

Share toX

New York, NY and Los Angeles, CA (PRWEB) August 13, 2013 -- Wedbush Securities, one of the nation’s leading broker-dealers and award-winning equity research firms, will host its annual Wedbush PacGrow Life Sciences Management Access Conference in New York from August 13 - 14, 2013. The conference connects institutional investors with management teams and senior executives from more than 75 prominent public and private companies across sectors including biotechnology, medical devices, emerging pharmaceuticals, healthcare services, managed care, medical diagnostics and life sciences tools.

In addition to various company presentations moderated by some of the firm’s leading research analysts, the Wedbush PacGrow team will host a panel discussion each day offering a deeper dive into trending industry topics. On Tuesday, August 13, PTC Therapeutics, Prosensa, Sarepta Therapeutics and Summit PLC will participate in a discussion on “Leaders in DMD and Rare Diseases.” Additionally, Ariosa Diagnostics, CellScape, Illumina, KellBenX, Natera and Sequenom will be joined by several physicians to lead a discussion on “Pre-natal Pioneers” on Wednesday, August 14.

“The Wedbush Equity Research team is proud to host its annual Life Sciences conference which uniquely highlights performance trends that support the investment community in their decision making processes,” said Mark Benson, Director of Research, Wedbush Securities. He continued by saying that the conference “offers an opportunity for our valued client base to connect with senior management from leading Life Sciences firms and receive critical industry insights.”

The following companies are scheduled to present at the Wedbush PacGrow Life Sciences Management Access Conference: Alexza, Algeta, Amicus Therapeutics, Anacor Pharmaceuticals, Ariosa Diagnostics, Avanir Pharmaceuticals, AxoGen, Biodel, Cadence Pharmaceuticals, Bluebird Bio, Cara Therapeutics, Cardica, Catabasis Pharmaceuticals, CellScape, Cepheid, Cerus, Chelsea Therapeutics, Civitas Therapeutics, CONMED Corporation, Coronado Biosciences, Curis, Delcath Systems, diaDexus, Durata Therapeutics, EndoStim, Emergent BioSolutions, Epizyme, Endocyte, Forma Therapeutics, Genocea, Gentium S.p.A., Good Start Genetics, GTx, Inc., Illumina, ImmunoGen, Insmed, Intercept Pharmaceuticals, IRIDEX, KellBenX, Kindred Bio, Lexicon Pharmaceuticals, Medivation, MEI Pharma, Metabolon, Natera, Novavax, NPS Pharmaceuticals, Ohr Pharmaceutical, Omeros Corp., OncoGenex Pharmaceuticals, Oncolytics Biotech, Oncothyreon, OvaScience, Pacira Pharmaceuticals, Palatin Technologies, Peregrine Pharmaceuticals, Prosensa, Prothena Corporation, PTC Therapeutics, Receptos, Regado Biosciences, Relypsa, Sangamo BioSciences, Sarepta Therapeutics, Sequenom, SIGA Technologies, Spectral Diagnostics, Spectrum Pharmaceuticals, Stemline Therapeutics, Summit PLC, Sunesis Pharmaceuticals, Synageva Biopharma, Tekmira Pharmaceuticals, Ultragenyx, Verastem, Xencor, Xoma and Zalicus.

The Wedbush PacGrow Life Sciences Management Access Conference is by invitation only. Please contact the Wedbush Equity Research team at (213) 688-4529 for additional information.

# # #

About Wedbush Equity Research
Wedbush Equity Research offers in-depth and differentiated research coverage across the consumer, life sciences, technology and industrial growth sectors. The team, comprised of more than 25 publishing analysts, generates timely, insightful analyses and the firm’s award-winning Wedbush Best Ideas List - an actively monitored compilation of stock ideas identifying outperformance trends over the forward 6 to 12 month period. Wedbush Equity Research has repeatedly been named a “Top Stock Picking Firm” by Barron’s and Zacks Investment Research, and consistently ranks among the industry’s leading performance surveys including StarMine’s “Analyst Performance Survey,” Financial Times’ “Top Analysts,” Institutional Investor’s “Rising Stars of Wall Street Research” and The Wall Street Journal’s “Best of the Street.”

About Wedbush Securities
Founded in 1955, Wedbush Securities is a leading investment firm that provides brokerage, clearing, investment banking, equity research, public finance, fixed income sales and trading, and asset management to individual, institutional and issuing clients. Headquartered in Los Angeles, with over registered 100 offices, the firm focuses on relentless service, client financial safety, continuity, and advanced technology. Wedbush Securities is the largest subsidiary of holding company WEDBUSH, Inc., which also includes affiliated firms Wedbush Bank, Wedbush Capital Partners, Wedbush Opportunity Partners, Wedbush Asset Management and Lime Brokerage LLC. Follow us on Twitter @Wedbush.

Matthew Chisum, Wedbush Securities, http://www.wedbush.com, +1 (213) 688-4459, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.